Health Care M&A Deals, Week Ending March 22, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price Gryphon Investors LEARN Behavioral N/A Ashley Addiction Treatment Aquila Recovery N/A eHealth Acquirer Target Price Henry Schein One Lighthouse 360 N/A Emergent Connect, LLC TouchstoneNet N/A Teladoc, Inc.... Read More »
Health Care M&A Deals, Week Ending March 15, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price AstraZeneca plc Exclusive rights to cancer immunotherapy $20,000,000 eHealth Acquirer Target Price Hill-Rom Holdings, Inc. Voalte, Inc. $180,000,000 K1 Investment Management, LLC Digital Pharmacist Inc. $100,000,000 ImagineSoftware ProviderAlly N/A... Read More »
Health Care M&A Deals, Week Ending March 8, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price AbleTo, Inc. Joyable N/A Biotechnology Acquirer Target Price Biogen Inc. Nightstar Therapeutics plc $877,000,000 Pfizer Inc. License to an immune tolerance therapy N/A Oncternal Therapeutics, Inc GTx, Inc. N/A... Read More »
Strong Spending on Healthcare Deals in February
On the dollar side, February 2019 looks hale and hearty with a combined total of $32.7 billion. The majority of that comes from one deal, not surprisingly. GE Healthcare’s (NYSE: GE) sale of its biopharma division to Danaher Corp. (NYSE: DHR) for $21.4 billion accounts for 65% of the month’s spending. Without it, the total would be $11.3 billion—still higher than the $9.7 billion turned in a year ago. The Biotechnology sector is driving a lot of spending this years, as we noted in the story on page 1. Three of the four billion-dollar-plus deals announced in February targeted biotech companies. The fourth, at $3.4 billion, came from Johnson & Johnson’s (NYSE: JNJ) acquisition of Auris... Read More »
February Puts a Chill on Healthcare Deal Volume
January was a fairly busy month for healthcare M&A, as regular readers already know. The 136 deals announced last month showed what results from the proverbial “January thaw.” As for February deal activity, the freeze was on. At press time, just 102 deals were on the books, down 25% compared with January and down 31% compared with February 2018, which turned in a scorching 147 deals. What’s going on? The federal government shut-down that dragged into January certainly had an effect. Some sources tell us that we’re back in the typical annual cycle, where the deal-making momentum from the previous fourth quarter spills over into January but quiets down through the rest of the first... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
